Lilly's diabetes drug works in studies, 2013 filing planned
This article was originally published in Scrip
Executive Summary
Eli Lilly & Co. said its experimental once-weekly diabetes drug dulaglutide effectively controlled blood sugar levels in a pair of late-stage studies.